NCT03198182View on ClinicalTrials.gov

A Study to Test the Effects of BMS-986036 on the Body in Healthy Japanese and Non-Japanese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

June 28, 2017

Primary Completion Date

September 22, 2017

Study Completion Date

September 22, 2017

Conditions
Metabolics
Interventions
DRUG

Placebo

Specified dose on specified days

DRUG

BMS-986036

Specified dose on specified days

Trial Locations (1)

90630

WCCT Global, Cypress

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY